Nitric Oxide-Releasing Compounds Inhibit the Production of Interleukin-2, -4 and -10 in Activated Human Lymphocytes
Open Access
- 16 September 2008
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 103 (4), 322-328
- https://doi.org/10.1111/j.1742-7843.2008.00275.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Nitric oxide induces CD4+CD25+Foxp3−regulatory T cells from CD4+CD25−T cells via p53, IL-2, and OX40Proceedings of the National Academy of Sciences, 2007
- INFLUENCE OF NITRIC OXIDE-DONATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON THE EVOLUTION OF ACUTE PANCREATITISShock, 2006
- Absence of inducible nitric oxide synthase modulates early reperfusion‐induced NF‐κB and AP‐1 activation and enhances myocardial damageThe FASEB Journal, 2002
- NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activationOncogene, 2000
- Nitric oxide selectively decreases interferon-γ expression by activated human T lymphocytes via a cGMP-independent mechanismImmunology, 1999
- Counter-Regulation of T Helper 1 Cell Proliferation by Nitric Oxide and Interleukin-2Biochemical and Biophysical Research Communications, 1997
- Nitric oxide inhibits the secretion of T‐helper 1‐ and T‐helper 2‐associated cytokines in activated human T cells‘paImmunology, 1997
- Nitric oxide‐donating properties of mesoionic 3‐aryl substituted oxatriazole‐5‐imine derivativesBritish Journal of Pharmacology, 1996
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functionsBritish Journal of Pharmacology, 1993